Catalysts for Sandoz Inc
291 tracked
Oct 9, 2025
approval
TRAVATAN Z (TRAVOPROST) โ FDA approval
TRAVOPROST
โ
Oct 8, 2025
approval
TRIAMCINOLONE ACETONIDE โ FDA approval
triamcinolone acetonide Rising
โ
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM โ FDA approval
PANTOPRAZOLE SODIUM
โ
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM โ FDA approval
PANTOPRAZOLE SODIUM
โ
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM โ FDA approval
PANTOPRAZOLE SODIUM
โ
Sep 24, 2025
recall
Sandoz Inc recall (Cls II)
Sandoz Inc
โ
Sep 23, 2025
approval
AZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
Sandoz Inc
โ
Sep 23, 2025
approval
RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
RITALIN LA
โ
Sep 23, 2025
approval
LEUPROLIDE ACETATE โ FDA approval
LEUPROLIDE ACETATE
โ
Sep 23, 2025
approval
FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) โ FDA approval
dexmethylphenidate hydrochloride ER
โ
Sep 22, 2025
approval
IRON SUCROSE โ FDA approval
succharated ferric oxide
โ
Sep 17, 2025
recall
Sandoz Inc recall (Cls II)
Sandoz Inc
โ
Aug 8, 2025
approval
IRON SUCROSE โ FDA approval
succharated ferric oxide
โ
Aug 1, 2025
approval
METHYLPREDNISOLONE โ FDA approval
MEDROL
โ
Aug 1, 2025
approval
METHYLPREDNISOLONE โ FDA approval
MEDROL
โ
Aug 1, 2025
approval
METHYLPREDNISOLONE โ FDA approval
MEDROL
โ
Jul 29, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) โ FDA approval
HYRIMOZ
โ
Jul 15, 2025
approval
DUREZOL (DIFLUPREDNATE) โ FDA approval
DIFLUPREDNATE
โ
Jul 9, 2025
recall
Sandoz Inc recall (Cls I)
Sandoz Inc
โ
Jul 9, 2025
recall
Sandoz Inc recall (Cls I)
Sandoz Inc
โ
May 20, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) โ FDA approval
HYRIMOZ
โ
Mar 7, 2025
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Mar 7, 2025
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Feb 12, 2025
approval
METHYLPREDNISOLONE ACETATE โ FDA approval
METHYLPREDNISOLONE ACETATE
โ
Feb 12, 2025
approval
METHYLPREDNISOLONE ACETATE โ FDA approval
METHYLPREDNISOLONE ACETATE
โ
Feb 10, 2025
approval
ENZEEVU (AFLIBERCEPT-ABZV) โ FDA approval
aflibercept biosimilar
โ
Dec 19, 2024
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Oct 24, 2024
approval
JUBBONTI (DENOSUMAB-BBDZ) โ FDA approval
JUBBONTI
โ
Sep 27, 2024
approval
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) โ FDA approval
UNASYN
โ
Aug 22, 2024
approval
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) โ FDA approval
UNASYN
โ